Reading this on a mobile device? Try our optimized mobile version here:

December 20, 2012
More than 2,700 companies nationwide are saving on lab supplies, shipping, news distribution, office products and more through the BIO Business Solutions cost-savings program. Find out how.

The news summaries appearing in BIO SmartBrief are based on original information from news organizations and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The information is not compiled or summarized by BIO. Questions and comments should be directed to SmartBrief at

  Today's Top Story 
  • Analysis: U.S. life science R&D spending will grow to $189.3B in 2013
    The U.S. life science sector is expected to spend $189.3 billion in research and development in 2013, up from $181.6 billion this year, driven by improved access to data, according to an analysis by Battelle and R&D Magazine. Out of the 275 life science firms that responded to a survey, a majority anticipate their R&D investment to grow over 2012 and 40% said they would participate in more collaborative research next year. (12/19) LinkedInFacebookTwitterEmail this Story
  Health Care & Policy 
  • FDA-approved trial to use telemonitoring, crowdsourcing approaches
    A Phase II clinical trial to examine the effectiveness of lisinopril in patients with multiple sclerosis by Transparency Life Sciences was approved by the FDA. The 12-month trial, which is the first to implement both remote monitoring and crowdsourcing techniques, will be performed by the biopharmaceutical startup with telehealth firm AMC Health. (12/18) LinkedInFacebookTwitterEmail this Story
  Company & Financial News 
  Industry Deals 
  Food & Agriculture 
  • EFSA supports safety of Monsanto's biotech maize pollen for food use
    A European Food Safety Authority panel concluded that Monsanto's MON 810 maize pollen is safe for use "in or as foods." "[T]he genetic modification in maize MON 810 does not constitute an additional health risk if maize MON 810 pollen is to replace maize pollen from non-GM maize in or as food," the panel said. The panel's scientific opinion supports Monsanto's application to bring the maize pollen in the market. FoodNavigator (12/19) LinkedInFacebookTwitterEmail this Story
  Industrial & Environmental 
  • House, Senate agree to keep Defense Dept.'s biofuels program
    The House of Representatives and the Senate have struck a deal to strip a provision from the defense authorization bill that would limit the military's ability to purchase biofuels. "This new compromise language will allow [the Department of Defense] to move forward with its clean energy agenda unscathed," said Stephanie Dreyer, a spokeswoman for the Truman National Security Project. The Hill/E2 Wire blog (12/18) LinkedInFacebookTwitterEmail this Story
  News from BIO 
  • BIOtechNOW
    BIOtechNOW is the first in a number of new products from BIO intended to enhance our communications with the biotech community -- not only with our members, but with other stakeholders as well. This e-newsletter, combined with its website, serves as our flagship in that effort. BIOtechNOW will offer original content that emphasizes the business needs of the industry; highlight BIO's advocacy efforts; and provide a portal to all BIO activities and events. Most importantly, it will spotlight for those outside the industry the value of biotechnology. Sign up for the e-newsletter. LinkedInFacebookTwitterEmail this Story
Learn more about BIO ->Conferences  |  Join BIO  |  Media  |  Issues  |  Industry

No man for any considerable period can wear one face to himself and another to the multitude, without finally getting bewildered as to which may be the true."
--Nathaniel Hawthorne,
American author

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Account Director:  Meryl Harold (202) 407-7828
A powerful website for SmartBrief readers including:
 Recent BIO SmartBrief Issues:   Lead Editor:  Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2012 SmartBrief, Inc.® Legal Information